<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11080">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00603837</url>
  </required_header>
  <id_info>
    <org_study_id>13223</org_study_id>
    <nct_id>NCT00603837</nct_id>
  </id_info>
  <brief_title>Warming Mattress Versus Polyethylene Wrapping to Prevent Hypothermia in Preterm Newborns.</brief_title>
  <official_title>Thermal Defense of Extremely Low Gestational Age Newborns (ELGANs) During Resuscitation: Exothermic Mattresses vs. Polyethylene Wrap</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oklahoma</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Oklahoma</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Mean axillary temperatures, taken during NICU resuscitation upon admission to the NICU, will
      not differ between VLBW babies who are occlusively wrapped and very low birth weight (VLBW)
      babies who are placed on thermal warming blankets.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2007</start_date>
  <completion_date type="Actual">November 2008</completion_date>
  <primary_completion_date type="Actual">November 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Neonatal Intensive Care Unit (NICU) Admission Temperature</measure>
    <time_frame>At time of admission to the NICU - usually within 10-15 min of birth</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Hypothermia</condition>
  <arm_group>
    <arm_group_label>Blanket</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm includes those Extremely low gestational age newborns (ELGANs) who are to be placed on a sodium acetate warming blanket after delivery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wrap</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm includes those ELGANs randomized to be wrapped in polyethylene after delivery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NeoWrap</intervention_name>
    <description>This is a polyethylene wrap that will be placed around the ELGAN from the neck down to prevent heat loss.</description>
    <arm_group_label>Wrap</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>InfaTherm</intervention_name>
    <description>A gel blanket containing a sodium acetate-based medium that, when activated, becomes exothermic and provides heat.</description>
    <arm_group_label>Blanket</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participants in this study will be selected from the inborn population at University
             Hospital. Eligible patients will be selected from the group of babies with estimated
             gestational ages of 24-28 weeks and &lt;1250g.

        Exclusion Criteria:

          -  Congenital anomalies with open lesions such as meningomyelocele, or omphaloceles

          -  Blistering skin conditions

          -  Resuscitation not performed secondary to infant being below limits of viability as
             assessed by the in-house attending physician (specifically, according to current NRP
             recommendations):

               -  Where gestation, birth weight, and/or congenital anomalies are associated with
                  almost certain early death, and unacceptably high morbidity is likely among the
                  rare survivors, resuscitation is not indicated. Exceptions may be made based on
                  parental desires.

                    -  Newborns with confirmed gestation age of less than 24 weeks or birth weight
                       less than 400 grams

                    -  Anencephaly

                    -  Confirmed Trisomy 13 or Trisomy 18 syndrome

                    -  Meconium staining of amniotic fluid

                    -  Birth assessment of gestational age &gt; 28 weeks or &gt;1250 grams

                    -  Maternal temp &gt;38 degrees C around the time of delivery.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>24 Weeks</minimum_age>
    <maximum_age>28 Weeks</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Douglas Dannaway, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Oklahoma</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Parker L Simon, DO, MPH</last_name>
    <role>Study Director</role>
    <affiliation>University of Oklahoma</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marilyn Escobedo, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Oklahoma</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Oklahoma University Health Sciences Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2009</verification_date>
  <lastchanged_date>October 12, 2009</lastchanged_date>
  <firstreceived_date>December 19, 2007</firstreceived_date>
  <firstreceived_results_date>July 24, 2009</firstreceived_results_date>
  <responsible_party>
    <name_title>Douglas C. Dannaway</name_title>
    <organization>Oklahoma University Health Science Center</organization>
  </responsible_party>
  <keyword>Hypothermia</keyword>
  <keyword>Prevention</keyword>
  <keyword>ELGANs(Extremely low gestational age neonates)</keyword>
  <keyword>Polyethylene Wrap</keyword>
  <keyword>Sodium Acetate Transport Mattress</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypothermia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Mothers were approached on the labor and delivery floor to consent for their child's participation in this study. Recruitment took place from May 2007 to November 2008.</recruitment_details>
      <pre_assignment_details>Three enrolled babies were not included in the analysis. One was found to have a birth weight greater than the cut-off, one was randomized to the wrong group, and one had an unrecorded delivery room temperature.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Blanket</title>
          <description>This arm includes those ELGANs who are to be placed on a sodium acetate warming blanket after delivery.</description>
        </group>
        <group group_id="P2">
          <title>Wrap</title>
          <description>This arm includes those ELGANs randomized to be wrapped in polyethylene after delivery.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Blanket</title>
          <description>This arm includes those ELGANs who are to be placed on a sodium acetate warming blanket after delivery.</description>
        </group>
        <group group_id="B2">
          <title>Wrap</title>
          <description>This arm includes those ELGANs randomized to be wrapped in polyethylene after delivery.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="20"/>
                <measurement group_id="B2" value="19"/>
                <measurement group_id="B3" value="39"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="20"/>
                <measurement group_id="B2" value="19"/>
                <measurement group_id="B3" value="39"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="7"/>
                <measurement group_id="B2" value="8"/>
                <measurement group_id="B3" value="15"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="13"/>
                <measurement group_id="B2" value="11"/>
                <measurement group_id="B3" value="24"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>United States</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="20"/>
                <measurement group_id="B2" value="19"/>
                <measurement group_id="B3" value="39"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Temperature</title>
          <units>Celsius degrees</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="36.5" spread="0.67"/>
                <measurement group_id="B2" value="36.1" spread="0.66"/>
                <measurement group_id="B3" value="36.3" spread="0.66"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Neonatal Intensive Care Unit (NICU) Admission Temperature</title>
        <description>Axillary temperature of the infant upon arrival to the neonatal intensive care unit.</description>
        <time_frame>At time of admission to the NICU - usually within 10-15 min of birth</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Blanket</title>
            <description>This arm includes those ELGANs who are to be placed on a sodium acetate warming blanket after delivery.</description>
          </group>
          <group group_id="O2">
            <title>Wrap</title>
            <description>This arm includes those ELGANs randomized to be wrapped in polyethylene after delivery.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="17"/>
                  <measurement group_id="O2" value="19"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Neonatal Intensive Care Unit (NICU) Admission Temperature</title>
            <description>Axillary temperature of the infant upon arrival to the neonatal intensive care unit.</description>
            <units>Celsius degrees</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="36.5" spread="0.67"/>
                  <measurement group_id="O2" value="36.1" spread="0.66"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>0.445</p_value>
            <method>t-test, 1 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Blanket</title>
          <description>This arm includes those ELGANs who are to be placed on a sodium acetate warming blanket after delivery.</description>
        </group>
        <group group_id="E2">
          <title>Wrap</title>
          <description>This arm includes those ELGANs randomized to be wrapped in polyethylene after delivery.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Technical difficulties with the polyethylene wrap were the main limitations (variation of use, heat loss during pulse oximeter adjustment).</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Doug Dannaway, MD</name_or_title>
      <organization>University of Oklahoma Health Sciences Center</organization>
      <phone>405-271-5215 ext 42048</phone>
      <email>douglas-dannaway@ouhsc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
